Artery Flow
Latest round
- Series A
Last raised
- Dec 2019
Total raised
- Undisclosed
Investors
- 2
About Artery Flow
Established in 2017 and based in Hangzhou, China, Artery Flow is a healthcare company that focuses on intelligent diagnostic of cardiovascular and cerebrovascular diseases on the basis of artificial intelligence, big data and relevant technologies. The company has established cooperation with clinicians in hundreds of hospitals to build R&D center for cardiovascular and cerebrovascular diseases. Meanwhile, the company has cooperated with Buffalo GVI in the US who is the world's top interventional treatment center. The company's core members composite with PhD and master's who graduate world-class universities, such as MIT and Imperial College. The company provides cardiovascular and cerebrovascular disease solutions, including intelligent screening, detection, diagnosis, and surgical planning. The company's products classified three categories, cardiovascular, cerebrovascular, and Artery Flow cloud platform. The cardiovascular includes DeepECG based on AI ECG online analysis system, AccuFFR based on non-invasive FFR analysis system for coronary CTA, DeepLV with AI automatic analysis software for left ventricular remodeling, which AccuFFR won the 2019 best innovation award in the cardiovascular field, and received conformite Europeenne (CE) certification. The cerebrovascular AneuFlow includes AneuFlow based on cerebral aneurysm auxiliary diagnosis system, and AccuStroke based on AI analysis system for ischemic stroke. The artery flow is a cloud based computing processing center. The company plans to promote commercial application of the product for cardiovascular disease functional assessment, to expand team of sales and R&D, and to perform R&D, registration, and declaration of new products.
Who invested in Artery Flow
2 investors across 2 rounds
See all investors in Artery Flow
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Artery Flow
Who invested in Artery Flow?
Artery Flow has 2 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Artery Flow raised?
Artery Flow has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Artery Flow last raise money?
Artery Flow's most recent round on record is a Series A, in Dec 2019.
What does Artery Flow do?
Established in 2017 and based in Hangzhou, China, Artery Flow is a healthcare company that focuses on intelligent diagnostic of cardiovascular and cerebrovascular diseases on the basis of artificial intelligence, big data and relevant technologies.
Where is Artery Flow headquartered?
Artery Flow is headquartered in Hangzhou, China.
Which VCs invest in companies like Artery Flow?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, Taibao Capital and Hengxu Capital back healthcare companies at Artery Flow's stage. Their profiles are linked below.
VCs backing healthcare startups at Series A
Raising like Artery Flow? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.